Papers
13
Total Citations
1,072
H-Index
10
About
Dr. Sanne Lof is a leading surgical researcher whose work has fundamentally shaped the field of minimally invasive pancreatic surgery. Her research centers on comparing the safety, oncologic outcomes, and learning curves of laparoscopic, robotic, and open approaches for distal pancreatectomy and pancreatoduodenectomy. Dr. Lof’s most impactful contribution is her leadership in developing the Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (2019, 478 citations), which established the first global standards for these complex procedures. She was also instrumental in the landmark DIPLOMA trial (2023, 121 citations), the first international randomized non-inferiority trial comparing minimally invasive versus open distal pancreatectomy for pancreatic cancer, providing crucial evidence on oncologic safety. Her work on conversion risks during robotic and laparoscopic surgery (2020, 60 citations) and her large-scale multicenter analyses comparing robotic and laparoscopic distal pancreatectomy (2021, 121 citations) have directly informed clinical decision-making worldwide. With over 1,000 total citations across her top papers, Dr. Lof has become a definitive voice in HPB surgery, helping to safely expand the role of minimally invasive techniques in the treatment of pancreatic disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic <i>versus</i> laparoscopic distal pancreatectomy: multicentre analysis121 citations · 2021
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10